The BIOAF chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the BIOAF chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The BIOAF stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View BIOAF Detailed Price Forecast - CNN Money||View BIOAF Detailed Summary - Google Finance|
|View BIOAF Detailed Summary - Yahoo! Finance||View BIOAF Stock Research & Analysis - Zacks.com|
|View BIOAF Trends & Analysis - Trade-Ideas||View BIOAF Major Holders - Barrons|
|View BIOAF Call Transcripts - NASDAQ||View BIOAF Breaking News & Analysis - Seeking Alpha|
|View BIOAF Annual Report - CompanySpotlight.com||View BIOAF OTC Short Report - OTCShortReport.com|
|View BIOAF Fundamentals - TradeKing||View BIOAF SEC Filings - Bar Chart|
|View Historical Prices for BIOAF - The WSJ||View Performance/Total Return for BIOAF - Morningstar|
|View the Analyst Estimates for BIOAF - MarketWatch||View the Earnings History for BIOAF - CNBC|
|View the BIOAF Earnings - StockMarketWatch||View BIOAF Buy or Sell Recommendations - MacroAxis|
|View the BIOAF Bullish Patterns - American Bulls||View BIOAF Short Pain Metrics - ShortPainBot.com|
|View BIOAF Stock Mentions - StockTwits||View BIOAF Stock Mentions - PennyStockTweets|
|View BIOAF Stock Mentions - Twitter||View BIOAF Investment Forum News - Investor Hub|
|View BIOAF Stock Mentions - Yahoo! Message Board||View BIOAF Stock Mentions - Seeking Alpha|
|View Insider Transactions for BIOAF - SECform4.com||View Insider Transactions for BIOAF - Insider Cow|
|View BIOAF Major Holdings Summary - CNBC||View Insider Disclosure for BIOAF - OTC Markets|
|View Insider Transactions for BIOAF - Yahoo! Finance||View Institutional Holdings for BIOAF - NASDAQ|
|View BIOAF Stock Insight & Charts - FinViz.com||View BIOAF Investment Charts - StockCharts.com|
|View BIOAF Stock Overview & Charts - BarChart||View BIOAF User Generated Charts - Trading View|
Bioasis Announces Stock Option Grants
Posted on Friday August 31, 2018
BIOASIS TECHNOLOGIES INC. , a biopharmaceutical company developing its xB3 TM proprietary platform technology for the delivery of therapeutics across the blood-brain barrier and the treatment of CNS disorders in areas of high unmet medical need, including brain cancers and neurodegenerative diseases, today announced that it has granted stock options to acquire a total of 1,020,000 common shares at ...
Aeromics, Inc. Appoints Pharmaceutical and Biotech Veterans Mark Day, Ph.D. and Thomas Zindrick, J.D. to Its Board of Directors
Posted on Thursday August 16, 2018
Aeromics, Inc. (“Aeromics” or “the Company”), a privately-held, clinical-stage pharmaceutical company focused on controlling cerebral edema, or brain swelling, for people affected by disabling and life-threatening severe ischemic stroke, announced today the appointments of Mark Day, Ph.D. and Thomas Zindrick, J.D. to the Aeromics board of directors. “Mark and Tom bring extensive leadership and drug development experience to our board,” said Jeffrey P. Draime, chairman of the board, Aeromics.
Bioasis Announces Closing of Previously Disclosed Private Placement
Posted on Monday August 13, 2018
OTCQB:BIOAF) (“Bioasis” or the “Company”), a biopharmaceutical company developing its xB3 TM proprietary platform technology for the delivery of therapeutics across the blood-brain barrier (BBB) for the treatment of central nervous system (CNS) disorders, today announced the close of its previously announced private placement of units, (the “Units”) by issuing an aggregate of 1,762,179 Units at a price of C$0.552 per Unit, for gross proceeds of C$972,722.80. Each Unit consists of one common share of the Company (a "Common Share") and one Common Share purchase warrant (each whole Common Share purchase warrant, a "Warrant"). Each Warrant entitles the registered holder to purchase one Common Share (a “Warrant Share”) at an exercise price of C$0.69 per Warrant Share for a period of 60 months from the date of closing.
Bioasis Announces Filing of Its Quarterly Financial Statements and MD&A for the Period Ending May 31, 2018
Posted on Monday July 30, 2018
BIOASIS TECHNOLOGIES INC. , a biopharmaceutical company developing its xB3 TM proprietary platform technology for the delivery of therapeutics across the blood-brain barrier and the treatment of CNS disorders in areas of high unmet medical need, including brain cancers and neurodegenerative diseases, today announced that it has filed its unaudited quarterly financial statements and management’s discussion ...